Related Experiment Videos
Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. Interrelationships.
Gynecologic Oncology
|January 1, 1987
Summary
Tumor DNA aneuploidy and S-phase fraction in cervical cancer correlate with malignancy grade. Evaluating DNA index with cell-cycle %S and malignancy grading improves biological identification of cervical cancers.
Area of Science:
- Oncology
- Cell Biology
- Gynecologic Pathology
Background:
- Cervical cancer prognosis is influenced by tumor biology.
- DNA content and cell-cycle S-phase fraction are key indicators of tumor proliferation.
- Histopathologic grading assesses tumor malignancy but may not fully capture biological behavior.
Purpose of the Study:
- To investigate the relationship between DNA index, S-phase fraction (%S), and histopathologic malignancy grade in uterine cervical squamous cell carcinomas.
- To determine if combining these parameters improves the identification of biologically distinct cervical cancers.
Main Methods:
- Flow cytometry was used to measure DNA index and S-phase fraction (%S) from pre-radiotherapy tumor biopsies of 90 cervical cancers.
- Histopathologic malignancy grading was performed on the same biopsies.
- Statistical analyses were conducted to assess correlations between DNA index, %S, and malignancy grades.
Main Results:
- DNA aneuploidy frequency increased significantly with higher S-phase fractions (31% for low %S, 73% for intermediate %S, 97% for high %S).
- S-phase fraction significantly increased with increasing DNA aneuploidy degree (P < 0.01).
- Malignancy grades showed heterogeneity within DNA index and %S subgroups, but high S-fraction was associated with higher malignancy grade.
Conclusions:
- Tumor DNA index and cell-cycle S-phase fraction are important prognostic indicators in cervical cancer.
- Histopathologic malignancy grading reflects tumor proliferative activity more closely than DNA index alone.
- Evaluating DNA index in conjunction with cell-cycle %S and malignancy grading offers a more reliable method for identifying biologically diverse cervical cancers.